The changes of serotonin-modulating anticonsolidation protein and dihydropyrimidinase-related protein 2 in the amygdala and blood of depressive rats

Authors

  • Lamiya Fazil Hasanova Academician Abdulla Garayev Institute of Physiology

Keywords:

depression, male and female rats, indirect ELISA test, amygdala, platelets, SMAP, serotonin-modulating anticonsolidation protein, DRP2, dihydropyrimidinase-related protein 2, anti-SMAP natural autoantibodies

Abstract

Nowadays depression is referred to psychiatric disease and is widely spread throughout the world. Pathogenesis of depression in humans is characterized by significant disturbances of serotonin turnover and its downregulation in the brain structures. The objective of the present study was the definition of the levels of serotonin-modulating anticonsolidation protein (SMAP) and dihydropyrimidinase-related protein 2 (DRP2) in the brain amygdala, platelets and of anti-SMAP natural autoantibodies in the depression Wistar rats of both sexes. A depression state in the rats was formed in the dominant model and its successful formation was confirmed in the forced swimming test by the decreased timeframe of active swimming. Through the application of an indirect ELISA test in the depressive male and female rats a downregulation of SMAP and DRP2 in the amygdala, upregulation of SMAP in the platelets of depressive male rats and noticeable downregulation of DRP2 in the platelets of depressive female rats, and sharp downregulation of anti-SMAP natural autoantibodies in the serum of depressive male rats was observed.

Downloads

Download data is not yet available.

Abstract views 118 | PDF Downloads: 24

References

Avrameas S. Natural autoantibodies: from “horror autotoxins” to “gnothi seaton”. Immunology Today. 1991;12:154-158.

Collins CM, Kloek J, Elliott JM. Parallel changes in serotonin levels in brain and blood following acute administration of MDMA. J Psychopharmacol. 2013 Jan;27(1):109-12. https://doi.org/10.1177/0269881112463123

Elliott JM, Kent A. Comparison of [125I]iod-lysergic acid diethylamide binding to human frontal cortex and platelet tissue. J Neurochem. 1989;53:191-196.

Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature. 1995 Aug 10;376(6540):509-14. https://doi.org/10.1038/376509a0.

Inagaki N, Chihara K, Arimura N, Ménager C, Kawano Y, Matsuo N, Nishimura T, Amano M, Kaibuchi K. CRMP-2 induces axons in cultured hippocampal neurons. Nat Neurosci. 2001 Aug;4(8):781-2. https://doi.org/10.1038/90476.

Malatynska E, Pinhasov A, Crooke JJ, Smith-Swintosky VL, Brenneman DE. Reduction of dominant or submissive behaviors as models for antimanic or antidepressant drug testing: technical considerations. J Neurosci Methods. 2007 Sep 30;165(2):175-82. https://doi.org/10.1016/j.jneumeth.2007.05.035.

Mekhtiev AA. Revealing in the brain of rats the protein possessing anticonsolidation properties. Bulletin Exper. Biol. Med. 2000;129:147-150.

Poletayev A.B. Regulatory autoantibodies. In book: Monoclonal Antibodies in Neurobiology. Novosibirsk, 1995:37-47.

Downloads


Abstract views 118
PDF Downloads: 24

Published

2022-12-30

How to Cite

1.
Hasanova LF. The changes of serotonin-modulating anticonsolidation protein and dihydropyrimidinase-related protein 2 in the amygdala and blood of depressive rats. Azerbaijan Journal of Physiology. 2022;37(2):7-12. https://ajp.az/index.php/ajp/article/view/37

Issue

Section

EXPERIMENTAL PHYSIOLOGY